• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACSCANTO II FLOW CYTOMETER; COUNTER, DIFFERENTIAL CELL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACSCANTO II FLOW CYTOMETER; COUNTER, DIFFERENTIAL CELL Back to Search Results
Catalog Number 338960
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/22/2020
Event Type  malfunction  
Manufacturer Narrative
Medical device expiration date: na.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that during use with a bd facscanto¿ ii flow cytometer the control counts of progenitor cells were out of upper limit.There was no reported patient impact.The following information was provided by the initial reporter, translated from spanish to english: control counts of progenitor cells out of upper limit.Patient samples for clinical use.If they were patient samples for clinical use, was there any impact to the patient? no results were released and no patient was treated.Were samples redrawn? yes.Was there any delay in treatment? no.Control counts of progenitor cells out of upper limit.There was not a new collection from patients.The samples were prepared and analyzed again in the instrument.
 
Event Description
It was reported that during use with a bd facscanto¿ ii flow cytometer the control counts of progenitor cells were out of upper limit.There was no reported patient impact.The following information was provided by the initial reporter, translated from spanish to english: control counts of progenitor cells out of upper limit.Patient samples for clinical use.If they were patient samples for clinical use, was there any impact to the patient? no results were released and no patient was treated.Were samples redrawn? yes.Was there any delay in treatment? no.Control counts of progenitor cells out of upper limit.There was not a new collection from patients.The samples were prepared and analyzed again in the instrument.
 
Manufacturer Narrative
After further evaluation of the complaint, it has been determined that the previously submitted mfr report# 2916837-2020-00180 was sent in error.The erroneous result that occurred was not on a patient sample it was a control sample and therefore, not considered to be a reportable malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD FACSCANTO II FLOW CYTOMETER
Type of Device
COUNTER, DIFFERENTIAL CELL
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
MDR Report Key10662622
MDR Text Key233335083
Report Number2916837-2020-00180
Device Sequence Number1
Product Code GKZ
UDI-Device Identifier00382903389605
UDI-Public0382903389605
Combination Product (y/n)N
PMA/PMN Number
K062087
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 01/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number338960
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/22/2020
Initial Date FDA Received10/12/2020
Supplement Dates Manufacturer Received01/28/2021
Supplement Dates FDA Received01/28/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-